Connect with us

Press Release

The 25-30 side chain of CTC Civil travel service chain is officially on the chain

Published

on

On December 23, Daniel Smith, CEO of Singapore Done Fund Management Institution and CEO of CTC, reached a strategic consensus with the heads of the six new side chains after in-depth communication and discussion for many times, and announced that the six side chains of CTC Global Cultural Travel Chain (VEA, LMA, HVA, MCO, WAS and VNC) were officially linked up. Due to the impact of the global COVID-19 epidemic, the strategic press conference that was scheduled to be held in Singapore was not held as scheduled. This multi-party strategic cooperation was finally reached in the form of electronic agreement.

Singapore Done the fund management organ CEO, the chief executive of CTC, Daniel Smith, for six side chain fixed anchor (Vienna, Austria, Lima, Peru, Havana, Cuba, Mexico City, Warsaw, Poland, Venice, Italy), the characteristics of human geography environment and beautiful landscape, said after the outbreak must personally go to feel the unique local customs. It is reported that six new side chain operation centers are set up in the business centers of six cities, and reached strategic consensus with the famous local travel companies.

Vienna, on the Danube river in northeastern Austria, is known as the “capital of music” in the world. Stopping on this city street full of musical notes is always a romantic scene, which makes people easily fall in love unawares, just like the nature of romance in Vienna. Most of Vienna’s tourist attractions are open all year round, such as The Schonbrunn Palace, hofburg Palace, Belfort Palace and the Vienna Museum, of which the Schonbrunn Palace is a UNESCO World Heritage Site.

Lima is the capital of Peru and the largest economic and cultural center in the country. It is located on the coastal irrigation oasis. In Lima is always most of the colonial period, South America is the most important political and commercial centers of power, therefore retained a large number of colonial buildings, such as large monasteries catacombs Francis, the central plaza, SAN street plaza and the buildings also earned Lima, scientific and cultural organization UNESCO awarded the “world cultural heritage” of reputation.

Located on the northwest coast of The Island of Cuba, Havana is the capital of the Republic of Cuba. It is located in the tropics, with a mild climate and pleasant seasons. It is known as the “Pearl of the Caribbean”, with many ancient churches, castles, squares, museums, monuments, parks, libraries and so on. The port city of distinctive and lasting appeal, classical and modern, the new world and old world, white and black, high culture and the lowbrow, all elements full of collision, there are telltale signs here, all seemingly independent individuals, together in the sunshine and the vibrant tropical port harmonious unify.

Mexico City is not only the capital of Mexico, but also the largest city in Mexico. Architectural buildings, historical sites, museums, palaces, monuments, shopping malls, government buildings, everything in Mexico City. The water garden on the Hochmirco Canal is the city’s largest tourist attraction, as well as landmark buildings such as the El Angel Daily Independent newspaper and the Angel of Independence Victory Column. Mexico City is the headquarters of many large media companies and Spanish newspapers. About 20% of the Mexican population lives in Mexico City, so this city is also known as the city that never sleeps.

Warsaw is the capital of the Republic of Poland, and the famous Warsaw Convention was signed here. Today, Warsaw still maintains the layout of the old and new cities. Various historical monuments and places of interest are mostly concentrated in the old city, attracting a large number of tourists from abroad every year. The Old Town is located on the west bank of the Vistula River. It is a cluster of majestic and majestic red spire buildings in the Middle Ages. The famous ancient buildings include the former Royal Palace known as the “Polish National Cultural Monument” and the most beautiful and magnificent Baroque building in Warsaw. Base Palace, Lazienki Palace, an outstanding representative of Polish classical architecture, etc.

Venice is the capital of the Veneto region in northern Italy, a world-famous historical and cultural city, and the birthplace of the Venetian school of painting. Its architecture, paintings, sculptures, operas, etc. have an extremely important position and influence in the world. The water city of Venice is the essence of the Renaissance, and it is also the only city in the world without cars. God shed tears here, but made it more crystal clear and tender, just like a romantic dream floating on the blue waves, enjoying “because of water There is the reputation of life, beautiful because of water, and prosperity because of water, and the reputation of “water city”.

In the context of the global epidemic situation is not optimistic and the economy is complex and changeable, the tourism industry is still an industry with stable market demand and a good development momentum in recent years. It has exceeded the global economic average growth rate for 7 consecutive years and has become the fastest growing industry one. With the integration of the global tourism industry and digitalization, the future will gradually achieve leapfrog development, bringing new horizons to the holiday economy and new development opportunities for the digital cultural tourism industry.

The so-called hero sees the same. The heads of CTC and the six new side chains agreed that the future development trend of the cultural and tourism industry will be to integrate blockchain technology into it, which is the need for the in-depth development of the integration of culture and tourism in the new economic environment. By building a new industrial ecological application system through blockchain technology, the cultural tourism industry will accelerate the circulation of assets, empower the growth of the digital economy, and promote the sustainable development of the cultural tourism industry’s digitization, capitalization, and ecologicalization.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

FS-Elliott to Be Featured on Now We Know with Steve Guttenberg Airing March 14 on CNBC

Published

on

Export, PA, United States, 13th Mar 2026 – The upcoming episode of Now We Know! with Steve Guttenberg, airing March 14, 2026 at 1pm ET on CNBC will feature FS-Elliott, a company specializing in the design and manufacturing of high-performance centrifugal air and gas compressors.

The segment provides viewers with a behind-the-scenes look at the engineering and precision required to produce industrial equipment that supports manufacturing, energy production, and critical infrastructure worldwide. Through advanced technology and meticulous design, FS-Elliott’s compressors help power operations across a wide range of industries.

From reliability and efficiency to long-term performance, the episode highlights the role that specialized equipment plays in keeping industrial systems running smoothly.

By showcasing FS-Elliott’s work, Now We Know! sheds light on the often-unseen technologies that support modern industry. The series continues its mission to reveal the innovation and expertise behind the systems that drive everyday life.

About Now We Know!

Hosted by actor, author, and businessman, Steve Guttenberg, this unique platform inspires the next generation of knowledge seekers and viewers around the country. Each episode features up to four industry experts who provide their own unique perspective on the topic at hand via a 6-8–minute segment produced by our team, bringing a fresh look at interesting narratives, moderated by the one and only Steve Guttenberg. 

Learn more at NowWeKnowTV.com

About FS-Elliott Co., LLC

FS-Elliott is a global leader in the engineering and manufacturing of oil-free, centrifugal air and gas compressors, with operations in over 90 countries. For over 60 years, FS-Elliott has combined a commitment to quality with advanced technology, enabling our customers to increase productivity and lower system operating costs. For more information, visit www.fs-elliott.com.

For more details, contact:

Now We Know! with Steve Guttenberg

(877) 546-9995

feature@nowweknowtv.com

nowweknowtv.com

SOURCE Now We Know! with Steve Guttenberg

All images courtesy of Now We Know! with Steve Guttenberg

 

Media Contact

Organization: Now We Know!with Steve Guttenberg

Contact Person: Media Relations

Website: https://nowweknowtv.com/

Email: Send Email

Contact Number: +18775469995

City: Export

State: PA

Country:United States

Release id:42579

The post FS-Elliott to Be Featured on Now We Know with Steve Guttenberg Airing March 14 on CNBC appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China

Published

on

SHENZHEN, CHINA China Medical System Holdings Limited (“CMS”, or the “Group”) is pleased to announce that on 13 March 2026, new drug for renal anaemia Desidustat Tablets (the “Product”) has been approved for marketing in China by the National Medical Products Administration of the People’s Republic of China (NMPA). The Product is a novel, oral HypoxiaInducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) for treating anaemia in non-dialysis adult, Chronic Kidney Disease (CKD) patients.

The approval of Desidustat Tablets will further strengthen the Group’s overall layout in the field of nephrology, and synergize with the marketed innovative drug Velphoro (Sucroferric Oxyhydroxide Chewable Tablets, indicated for CKD hyperphosphatemia). Through the efficient linkage of nephrology expert resources and channel networks, the Group is expected to rapidly promote the large-scale clinical application of Desidustat Tablets, providing differentiated treatment options for Chinese CKD patients with renal anaemia and making a positive contribution to the Group’s performance.

More information about Desidustat Tablets and Renal Anaemia

As a novel oral HIF-PHI, the Product’s mechanism of action promotes erythropoiesis through increasing endogenous erythropoietin, improving iron availability and reducing hepcidin. Its China Phase III clinical trial has demonstrated positive results. The primary endpoint of the haemoglobin (Hb) mean change from baseline to Week 7-9 has indicated that, Desidustat is more effective than placebo in increasing Hb level. Results from the extension study demonstrate that the Product can maintain Hb level within the target range over the long term with acceptable safety. In addition, the Product significantly reduces hepcidin levels and ameliorates iron metabolism disorders.

There is still a large unmet need in the treatment of anaemia in CKD patients in China. It is estimated that there are more than 120 million CKD patients in China[1]. Anaemia is one of the frequent complications of CKD, which exhibits a progressively increasing incidence with disease progression. A survey in China showed that the prevalences of anaemia in patients at CKD stage 1 to 5 were 22.0%, 37.0%, 45.4%, 85.1%, and 98.2%, respectively[2]. The target-achieving rate (the Hb level reaching the target value (110~120g / L)) has increased to 51.5% for haemodialysis CKD patients with anaemia[3], but is still only 8.2% for anaemia patients in non-dialysis CKD[4]. The Product is administrated orally, thus expecting to improve the treatment compliance of patients and to meet the unmet treatment needs in the field of CKD anaemia.

Desidustat Tablets have been approved for marketing in India.

CMS INTERNATIONAL DEVELOPMENT AND MANAGEMENT LIMITED, a wholly-owned subsidiary of the Group, obtained an exclusive license for the Product from Zydus Lifesciences Limited (earlier known as Cadila Healthcare Limited) pursuant to a License Agreement with an effective date of 20 January 2020.

The Group adheres to its core strategy of “innovation-driven”, having established a tiered and multi-dimensional innovation product portfolio with abundant reserves: 7 new drugs have been approved for marketing, 6 are currently under marketing review, and nearly 20 projects are about to initiate or are progressing through clinical trials. Through a dual-engine innovation approach combining collaborative development and in-house R&D, the Group continuously enriches its innovative pipeline centered on first-in-class (FIC) and best-in-class (BIC) products, efficiently advancing clinical development and commercialization. Moving forward, CMS will remain clinical needs-driven to deliver more quality pharmaceutical solutions, steadfastly advancing toward the goal of becoming a specialty-focused, innovation-excellent multinational pharmaceutical enterprise.

About CMS

CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.

CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.

CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the Cardiovascular-Kidney-Metabolic/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.

Reference

1. ZhangL, WangF, WangL, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012, 379(9818):815-822. DOI: 10.1016/S0140-6736(12)60033-6

2. Chinese Expert Consensus on the Diagnosis and Treatment of Renal Anemia (2014 Revised Edition)[J]. Chinese Journal of Nephrology, 2014, 30(9): 712-716. DOI: 10.3760/cma.j.issn.1001-7097.2014.09.015

3. 19th CSN Critical Care & Blood Purification Congress, Chinese Medical Association (July 2-5, 2025)

4. Chinese Expert Consensus on the Diagnosis and Treatment of Renal Anemia (2018 Revised Edition)[J]. Chinese Journal of Nephrology, 2018, 34(11): 860-866. DOI: 10.3760/cma.j.issn.1001-7097.2018.11.012

CMS Disclaimer and Forward-Looking Statements

This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.

This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.

 

Media Contact

Brand: China Medical System Holdings Ltd.

Contact: CMS Investor Relations

Website: https://web.cms.net.cn/en/home/

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Healing Beyond Surgery: Paramedical Tattooing Takes the Stage at Gather and Grow Cancer Event in Scottsdale

Published

on

Scottsdale, AZ April 11, 2026 At the upcoming Gather and Grow conference, nationally recognized paramedical tattoo specialist Jayd Hernandez will lead an educational session highlighting how restorative tattooing is helping cancer survivors reclaim confidence, identity, and a sense of self after treatment.

Hernandez will present Transformative Tattooing: Restoring Identity Through Paramedical Art on Saturday, April 11, 2026, from 12:30 to 1:00 PM MST at the Hotel Valley Ho in Scottsdale.

The session explores how paramedical tattooing, including hyper realistic 3D areola restoration and scar camouflage, extends healing beyond surgery. Blending medical precision with artistic care, this specialized practice supports emotional recovery and body confidence for individuals navigating life after cancer.

Hernandez is a nationally recognized expert in 3D areola and nipple tattooing, specializing in hyper realistic restoration for breast cancer survivors following mastectomy. With more than a decade of experience and over 1,000 restorative procedures performed, her work is known for delivering results that are both visually lifelike and emotionally restorative.

She holds a National Provider Identifier, allowing eligible patients to pursue medical reimbursement for their procedures. Her trauma informed process and advanced aesthetic technique have led many reconstructive surgeons to refer patients directly to her studio for final stage care.

As the founder of one of the industry’s most comprehensive paramedical tattoo training programs, Hernandez has also trained a new generation of artists in medically responsible, client centered care. Her work has been recognized across both medical and beauty communities, helping bridge the gap between aesthetics and post surgical aftercare.

In addition to her presentation at Gather and Grow, Hernandez will attend the Oncology Clinical Updates Review and Renew in Sedona on April 11 and 12, 2026, where she has been invited as an Honorarium Attendee, reflecting growing recognition of her expertise within oncology adjacent and medical aesthetics communities.

Later this month, Hernandez is also scheduled to appear as a panel speaker on beauty business ownership at the Aveda Institute Phoenix, contributing her perspective on entrepreneurship within the beauty industry.

The Gather and Grow event brings together professionals, educators, and advocates focused on innovation, healing, and patient centered care in the cancer community.

For more information, visit:

https://jaydhernandez.com/

Media Contact

Organization: Jayd Hernandez

Contact Person: Jayd Hernandez

Website: https://jaydhernandez.com/

Email: Send Email

Contact Number: +14805765230

Country:United States

Release id:42543

The post Healing Beyond Surgery: Paramedical Tattooing Takes the Stage at Gather and Grow Cancer Event in Scottsdale appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST